<DOC>
	<DOCNO>NCT00731029</DOCNO>
	<brief_summary>This comparative vaccination study reactogenicity immunogenicity thiomersal-free formulation Influsplit SSW® 2002/2003 versus standard formulation Influsplit SSW® 2002/2003 individual 18 year .</brief_summary>
	<brief_title>Reacto &amp; Immunogenicity TF Formulation Influsplit SSW® 2002/03 v/s Std Formulation Influsplit SSW® 2002/03</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy subject capable vaccinated subject primary disease ( cardiovascular condition , metabolic condition diabetes mellitus , respiratory disease ) capable vaccinate age 18 year want vaccinate influenza doctor considers prophylactic influenza immunisation indicate . The inclusion individual immunise 2001/2002 season prefer . Written consent vaccination must available subject brief study understandable language . Use study unlicensed medication administration vaccine study vaccine within 30 day precede vaccination and/or study period Acute disease begin study Acute clinically significant change lung , cardiovascular system , liver kidney function , identify physical examination laboratory test Pregnancy Women would like fall pregnant period day vaccination 1 month thereafter Known allergic reaction might cause one ingredient vaccine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Thiomersal-free influenza split vaccine 2002/2003</keyword>
	<keyword>Influsplit SSW®/Fluarix™ 2002/2003</keyword>
</DOC>